Covered recipient · General Payments record
KAROLJOHN S DELARA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,321.64
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $289.12 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $164.01 | 13 |
| ABBVIE INC. | $39.58 | 2 |
| Novo Nordisk AS | $33.44 | 2 |
| ViiV Healthcare Company | $29.06 | 1 |
| Xeris Pharmaceuticals, Inc. | $23.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.33 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107007257 | CMS |
| ABBVIE INC. | $22.25 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107007259 | CMS |
| Amgen Inc. | $16.78 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117236406 | CMS |
| Amgen Inc. | $8.35 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117539126 | CMS |
| Amgen Inc. | $5.37 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117236408 | CMS |
| Amgen Inc. | $23.64 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117236416 | CMS |
| Amgen Inc. | $2.84 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117236418 | CMS |
| Amgen Inc. | $5.06 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117236410 | CMS |
| Amgen Inc. | $20.76 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117236420 | CMS |
| Amgen Inc. | $28.00 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117539128 | CMS |
| Amgen Inc. | $13.32 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117236412 | CMS |
| Amgen Inc. | $19.99 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117236422 | CMS |
| Amgen Inc. | $5.13 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117236424 | CMS |
| Amgen Inc. | $8.71 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117539130 | CMS |
| Amgen Inc. | $6.06 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117236414 | CMS |
| Novo Nordisk Inc | $14.47 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100428099 | CMS |
| Novo Nordisk Inc | $18.97 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100538858 | CMS |
| ViiV Healthcare Company | $29.06 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112819649 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.03 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144630587 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.